-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Predictive Oncology Inc. annual/quarterly Income Tax Expense (Benefit) history and growth rate from Q1 2017 to Q1 2023.
- Predictive Oncology Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2023 was $0.000.
- Predictive Oncology Inc. annual Income Tax Expense (Benefit) for 2023 was $0.000.
- Predictive Oncology Inc. annual Income Tax Expense (Benefit) for 2022 was $0.000.
- Predictive Oncology Inc. annual Income Tax Expense (Benefit) for 2021 was -$662K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)